Authors:
Liu, ML
Shibata, MA
Von Lintig, FC
Wang, WL
Cassenaer, S
Boss, GR
Green, JE
Citation: Ml. Liu et al., Haploid loss of Ki-ras delays mammary tumor progression in C3 (1)/SV40 Tagtransgenic mice, ONCOGENE, 20(16), 2001, pp. 2044-2049
Authors:
Shibata, MA
Yoshidome, K
Shibata, E
Jorcyk, CL
Green, JE
Citation: Ma. Shibata et al., Suppression of mammary carcinoma growth in vitro and in vivo by inducible expression of the Cdk inhibitor p21, CANC GENE T, 8(1), 2001, pp. 23-35
Authors:
Wigginton, JM
Park, JW
Gruys, ME
Young, HA
Jorcyk, CL
Back, TC
Brunda, MJ
Strieter, RM
Ward, J
Green, JE
Wiltrout, RH
Citation: Jm. Wigginton et al., Complete regression of established spontaneous mammary carcinoma and the therapeutic prevention of genetically programmed neoplastic transition by IL-12/pulse IL-2: Induction of local T cell infiltration, Fas/Fas ligand geneexpression, and mammary epithelial apoptosis, J IMMUNOL, 166(2), 2001, pp. 1156-1168
Authors:
Guo, CH
Yu, SH
Davis, AT
Wang, HM
Green, JE
Ahmed, K
Citation: Ch. Guo et al., A potential role of nuclear matrix-associated protein kinase CK2 in protection against drug-induced apoptosis in cancer cells, J BIOL CHEM, 276(8), 2001, pp. 5992-5999
Authors:
Green, JE
Shibata, MA
Shibata, E
Moon, RC
Anver, MR
Kelloff, G
Lubet, R
Citation: Je. Green et al., 2-difluoromethylornithine and dehydroepiandrosterone inhibit mammary tumorprogression but not mammary or prostate tumor initiation in C3(1)/SV40 T/t-antigen transgenic mice, CANCER RES, 61(20), 2001, pp. 7449-7455
Authors:
Wu, K
Kim, HT
Rodriquez, JL
Munoz-Medellin, D
Mohsin, SK
Hilsenbeck, SG
Lamph, WW
Gottardis, MM
Shirley, MA
Kuhn, JG
Green, JE
Brown, PH
Citation: K. Wu et al., 9-cis-Retinoic acid suppresses mammary tumorigenesis in C3(1)-simian virus40 T antigen-transgenic mice, CLIN CANC R, 6(9), 2000, pp. 3696-3704
Authors:
Cardiff, RD
Anver, MR
Gusterson, BA
Hennighausen, L
Jensen, RA
Merino, MJ
Rehm, S
Russo, J
Tavassoli, FA
Wakefield, LM
Ward, JM
Green, JE
Citation: Rd. Cardiff et al., The mammary pathology of genetically engineered mice: the consensus reportand recommendations from the Annapolis meeting, ONCOGENE, 19(8), 2000, pp. 968-988
Authors:
Green, JE
Shibata, MA
Yoshidome, K
Liu, ML
Jorcyk, C
Anver, MR
Wigginton, J
Wiltrout, R
Shibata, E
Kaczmarczyk, S
Wang, W
Liu, ZY
Calvo, A
Couldrey, C
Citation: Je. Green et al., The C3(1)/SV40 T-antigen transgenic mouse model of mammary cancer: ductal epithelial cell targeting with multistage progression to carcinoma, ONCOGENE, 19(8), 2000, pp. 1020-1027
Authors:
Yoshidome, K
Shibata, MA
Couldrey, C
Korach, KS
Green, JE
Citation: K. Yoshidome et al., Estrogen promotes mammary tumor development in C3(1)/SV40 large T-Antigen transgenic mice: Paradoxical loss of estrogen receptor alpha expression during tumor progression, CANCER RES, 60(24), 2000, pp. 6901-6910
Authors:
Yokoyama, Y
Green, JE
Sukhatme, VP
Ramakrishnan, S
Citation: Y. Yokoyama et al., Effect of endostatin on spontaneous tumorigenesis of mammary adenocarcinomas in a transgenic mouse model, CANCER RES, 60(16), 2000, pp. 4362-4365
Authors:
Maroulakou, IG
Shibata, MA
Anver, M
Jorcyk, CL
Liu, ML
Roche, N
Roberts, AB
Tsarfaty, I
Reseau, J
Ward, J
Green, JE
Citation: Ig. Maroulakou et al., Heterotopic endochondrial ossification with mixed tumor formation in C3(1)/Tag transgenic mice is associated with elevated TGF-beta1 and BMP-2 expression, ONCOGENE, 18(39), 1999, pp. 5435-5447
Authors:
Yu, SH
Davis, AT
Guo, CH
Green, JE
Ahmed, K
Citation: Sh. Yu et al., Differential targeting of protein kinase CK2 to the nuclear matrix upon transient overexpression of its subunits, J CELL BIOC, 74(1), 1999, pp. 127-134
Authors:
Shibata, MA
Liu, ML
Knudson, MC
Shibata, E
Yoshidome, K
Bandey, T
Korsmeyer, SJ
Green, JE
Citation: Ma. Shibata et al., Haploid loss of bax leads to accelerated mammary tumor development in C3(1)/SV40-TAg transgenic mice: reduction in protective apoptotic response at the preneoplastic stage, EMBO J, 18(10), 1999, pp. 2692-2701